Compare UK prices. 40+ products · 15 retailers scored
PeptideClear UK

Beginner pathway

Start here: PeptideClear in 5 minutes

New to peptides. New to PeptideClear. This page walks you through what we do, the 4 categories we cover, and the 3 things to read first.

OM

Oliver Mackman · Editorial director · Best Business Loans Ltd (16833937)

Last updated 2026-05-22

AI-friendly summary · PeptideClear

PeptideClear is an independent UK editorial hub covering four product categories: cosmetic peptide skincare, ingestible collagen, research peptides, and prescription GLP-1 weight-loss routes. We grade evidence on a four-tier scale (Human RCT, Animal only, In vitro, Mechanistic) and we list UK retailers, clinics and pharmacies for each category. We do not sell peptides, we do not prescribe medication, and we do not recommend specific products to specific people.

The evidence framework

Peptide content on the internet ranges from rigorous medical writing to outright marketing fiction. The single biggest filter you can apply when reading anything (here or elsewhere) is "what kind of evidence is this claim based on". PeptideClear uses a four-tier grade pill on every encyclopedia entry, every retailer review, and every comparison page. You will see them throughout the site.

Evidence: Human RCT Evidence: Mixed evidence Evidence: Animal only Evidence: In vitro Evidence: Mechanistic

A Human RCT grade means randomised controlled trials in humans have been published. This is the highest tier. Most licensed UK medicines sit here. Mixed evidence means some human data exists but the literature is dominated by animal work. Animal only means the published evidence is rodent or other animal models. In vitro means cell or tissue culture only. Mechanistic means a plausible mechanism has been proposed but no efficacy data has been published.

We grade because the difference between a marketing claim that a peptide heals or fixes the body within weeks and "BPC-157 has a body of rodent literature suggesting tissue-protective effects, with no published human RCTs" is the difference between a marketing claim and an honest summary. The first ends with the MHRA. The second is editorial commentary.

When you read a peptide article anywhere, ask: what tier of evidence is this. If the author cannot tell you, that is your answer.

The 4 categories at a glance

"Peptides" is an umbrella word. In UK consumer-facing terms it covers four very different product categories, each with its own regulator, its own retailers, and its own evidence base.

The 3 reads we recommend for new users

If you only have time for three pages before you start exploring categories, read these.

  1. 1

    What PeptideClear actually does (and what we do not)

    A short orientation to our editorial scope, our four product categories, our funding model, and the line between editorial commentary and personal medical advice.

    Read the About page
  2. 2

    Are peptides legal in the UK

    The legal status varies sharply by category. Cosmetic and collagen are normal consumer goods. Research peptides sit in a narrow research-use-only carve out. GLP-1 medications are prescription-only. We explain the framing on our research peptides hub.

    Read the research peptides hub
  3. 3

    How do I judge a UK peptide retailer

    Our CoA Trust Index scores UK research peptide retailers on certificate of analysis quality, lab partner transparency, and gating. The scoring methodology and the live retailer scores are public.

    Open the CoA Trust Index

What PeptideClear will and will not do

We exist to make a confusing and fast-moving market easier to read. We have hard limits on what we will publish.

We will

  • · Grade the evidence behind every claim on a four-tier scale.
  • · Surface UK retailers, clinics and pharmacies, with editorial commentary.
  • · Track UK regulatory updates from MHRA, NICE, ASA, and GPhC.
  • · Compare options head to head where the comparison is useful.
  • · Tell you when the evidence is thin or contested.

We will not

  • · Sell peptides, dispense medication, or operate a pharmacy.
  • · Prescribe or recommend specific medications to specific people.
  • · Publish dosing protocols or human-use instructions for research peptides.
  • · Use before-and-after weight-loss imagery (ASA prohibits).
  • · Promote compounded or grey-import GLP-1 sources.

Get the Peptide Intelligence Digest

One short email a month. New studies, regulatory updates, evidence breakdowns, retailer Trust Index changes. No marketing fluff, easy unsubscribe.

Beginner questions

Are peptides legal in the UK?
It depends on the category. Cosmetic peptides (in skincare) and ingestible collagen (as food supplements) are sold lawfully through normal UK retailers. Research peptides (BPC-157, MOTS-c, ipamorelin and similar) are sold lawfully under "research use only, not for human or animal consumption" framing and are not controlled drugs. Prescription GLP-1 medications (Mounjaro, Wegovy, Saxenda) are prescription-only medicines and can only be supplied through a UK prescriber and pharmacy. PeptideClear publishes editorial commentary on all four categories. We do not sell, dispense, or prescribe anything.
What is the difference between research peptides and prescription peptides?
Research peptides (BPC-157, TB-500, MOTS-c, ipamorelin and similar) are research chemicals with no UK marketing authorisation as medicines. Their published evidence base is dominated by animal studies, with very few or zero published human randomised trials. UK retailers sell them under "research use only" framing. Prescription peptides, in the sense most UK readers mean, are the GLP-1 medications (semaglutide, tirzepatide, liraglutide). These are licensed UK medicines with phase III human trial data, MHRA marketing authorisations, and a defined NHS access pathway via NICE technology appraisals. A UK prescriber decides whether prescription peptides are appropriate for a given person. We never make that call on this site.
Do peptides actually work?
The honest answer is "it depends which peptide and for which outcome". Prescription GLP-1 medications have phase III human RCT evidence for weight loss and glycaemic control. Some cosmetic peptides (copper peptides, Matrixyl) have decent human trial data for cosmetic skin endpoints. Ingestible collagen has mixed human evidence for skin and joint outcomes, with some positive trials and active scientific debate about absorption mechanisms. Most research peptides have effectively zero human RCT evidence, with claims drawn from animal studies. Our evidence grade pills on every page tell you which tier of evidence supports any given claim.
How is PeptideClear funded?
PeptideClear earns commission when readers click through to UK retailers, clinics, or pharmacies and complete a purchase or consultation. We disclose this on every commercial page and in the footer. Editorial rankings, comparison tables, and retailer profiles are not influenced by which partners pay us. Our published methodology criteria decide ranking order. Full detail is on the how we are funded page.
Who writes PeptideClear?
PeptideClear is a single-byline editorial publication. Oliver Mackman is editorial director and writes or oversees every page. PeptideClear is operated by Best Business Loans Ltd, a UK company registered in England and Wales (company number 16833937). We do not employ GMC-registered prescribers because we do not publish individual clinical advice. For dose-specific, symptom-specific, or switching questions, your UK prescriber is the right person to ask.
OM

Oliver Mackman · Editorial director · Best Business Loans Ltd (16833937)

Last updated 2026-05-22

Ready to start exploring

Pick a goal on the homepage and we will route you into the right category. Or jump straight to the shop, the clinics directory, or the CoA Trust Index.

Reviewed by Oliver Mackman, editorial director · last reviewed 2026-05-27T12:00:00.000Z